The expression of common fragile sites and genetic predisposition to squamous cell lung cancers.

[1]  B. Dave,et al.  Nonrandom distribution of mutagen-induced chromosome breaks in lymphocytes of patients with different malignancies. , 1994, International journal of oncology.

[2]  M. Tonato,et al.  Expression of aphidicolin-induced fragile sites in lymphocytes of patients with breast cancer. , 1993, Cancer genetics and cytogenetics.

[3]  P. Vernole,et al.  Fragile site induction by aphidicolin may be increased in parents of neuroblastoma patients. , 1990, Cancer genetics and cytogenetics.

[4]  M. Law,et al.  Genetic predisposition to lung cancer. , 1990, British Journal of Cancer.

[5]  B. Porfirio,et al.  Patients with different lung cancers show normal expression of fra(3)(p14.2) in aphidicolin-treated lymphocyte cultures. , 1989, Cancer genetics and cytogenetics.

[6]  P. Li,et al.  The expression frequency of common fragile sites and genetic susceptibility to lung cancers. , 1989, Cancer genetics and cytogenetics.

[7]  T. Hsu,et al.  Mutagen‐induced chromosome fragility within peripheral blood lymphocytes of head and neck cancer patients , 1989, Head & neck.

[8]  D. Caporossi,et al.  Common fragile sites and human cancer. A study on lymphocytes from neuroblastoma patients. , 1988, Cancer genetics and cytogenetics.

[9]  M. L. Beau.  Chromosomal fragile sites and cancer-specific breakpoints--a moderating viewpoint. , 1988 .

[10]  F. Hecht,et al.  Of fragile sites and cancer chromosome breakpoints. , 1988, Cancer genetics and cytogenetics.

[11]  J. Osinga,et al.  Deletion of a DNA sequence at the chromosomal region 3p21 in all major types of lung cancer , 1987, Nature.

[12]  Y. Kawakami,et al.  Sister chromatid exchange induction by benzo(a)pryene in cultured peripheral blood lymphocytes of lung cancer patients and healthy individuals with or without familial history of neoplasms , 1987, International journal of cancer.

[13]  M. L. Beau.  Chromosomal fragile sites and cancer-specific rearrangements. , 1986 .

[14]  R. Elston,et al.  Increased familial risk for lung cancer. , 1986, Journal of the National Cancer Institute.

[15]  S. Brown,et al.  Localization of the human aryl hydrocarbon hydroxylase gene to the 2q31→2pter region of chromosome 2 , 1985, Annals of human genetics.

[16]  J. Yunis,et al.  Constitutive fragile sites and cancer. , 1984, Science.

[17]  F. Hecht,et al.  Cancer chromosome breakpoints and common fragile sites induced by aphidicolin. , 1984, Cancer genetics and cytogenetics.

[18]  H. Evans,et al.  Cigarette smoke-induced DNA damage and lung cancer risks , 1980, Nature.

[19]  B. Czepulkowski,et al.  Human cytogenetics : a practical approach , 1986 .

[20]  G. Sutherland,et al.  Heritable fragile sites on human chromosomes. XI. Factors affecting expression of fragile sites at 10q25, 16q22, and 17p12. , 1984, American journal of human genetics.